FAST Generics Act Reintroduced But Lawmakers May Have To Use Separate Bill To Go Around E&C

/ April 10, 2017 at 7:22 PM
Rep. Peter Welch's (D-VT) Risk Evaluation and Mitigation Strategies (REMS) reform bill, the Fair Access for Safe and Timely (FAST) Generics Act, was reintroduced in the House last week, but lawmakers may need to push a separate bill to make headway on REMS reforms this session. While the Welch bill has been referred to the House Energy & Commerce Committee, one Democratic drug pricing lobbyist tells Inside Health Policy that E&C leadership doesn't appear interested in moving the bill,...

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.